<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000523453"><TermName>Targretin</TermName><TermPronunciation>(tar-GREH-tin)</TermPronunciation><TermDefinition><DefinitionText>A drug used to treat skin problems caused by cutaneous T-cell lymphoma that have not gotten better after other treatment. It is also being studied in the treatment of other types of cancer. Targretin is a type of retinoid. Also called bexarotene and LGD1069.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000718539" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Targretin&quot;" language="en" id="_3"/><MediaLink ref="CDR0000718538" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Targretin&quot;" language="es" id="_4"/><SpanishTermName>Targretin</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para tratar problemas  de la piel  por causa del linfoma cutáneo de células T que no han mejorado después del tratamiento. Asimismo, está en estudio para el tratamiento de otros tipos de cáncer. El Targretin es un tipo de retinoide. También se llama bexaroteno y LGD1069.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2006-12-01</DateFirstPublished><DateLastModified>2006-11-29</DateLastModified><RelatedInformation><RelatedDrugSummaryRef href="CDR0000500219">Bexarotene</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
